Trial Profile
A Phase I, Open-label to the Route of Administration, Single-blind to the ID Doses, Randomised, Active-controlled, Parallel Study to Evaluate the Safe Usability of 4Fluart ID Suspension for Injection in Adult Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 04 Mar 2021
Price :
$35
*
At a glance
- Drugs Quadrivalent-inactivated-influenza-vaccine-Fluart-Innovative-Vaccines (Primary) ; Influenza virus vaccine
- Indications Influenza virus infections
- Focus Adverse reactions
- Sponsors Fluart Innovative Vaccines
- 28 Feb 2021 Status changed from recruiting to completed.
- 08 Mar 2018 New trial record